Under hypoxic conditions, the activation of hypoxia-inducible factor 1-alpha (HIF-1α) can induce EMT in HCC cells and enhance drug resistance by upregulating MDR1 expression, suggesting that HIF-1α suppression can enhance the efficacy of chemotherapy [125]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.